glp 1 drugs and vision problems GLP-1 Could Double Risk of Severe Eye Disease in Older Adults With Diabetes GLP-1 Drugs and Risk for

doi: 10.1111/jdi.13247

These are primarily indicated for type 2 diabetes management rather than obesity treatment, though they may contribute to modest weight loss

Keywords: GLP-1 receptor agonists, Anesthesia, Perioperative period, Fasting, Ultrasound Background Nowadays, metabolic disorders are increasing rapidly worldwide, and incretin-based therapies have gained a pivotal role in the management of type 2 diabetes and obesity [1, 2]

Japans regulatory landscape emphasizes rigorous safety standards, supporting the demand for effective type 2 diabetes therapies

Yes and not only because of weight loss

Retrieved from Bray GM